NM_198578.4(LRRK2):c.843T>G (p.Asn281Lys) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Nov 14, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004518019.1

Allele description [Variation Report for NM_198578.4(LRRK2):c.843T>G (p.Asn281Lys)]

NM_198578.4(LRRK2):c.843T>G (p.Asn281Lys)

Gene:

LRRK2:leucine rich repeat kinase 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12q12

Genomic location:

Preferred name:

NM_198578.4(LRRK2):c.843T>G (p.Asn281Lys)

HGVS:

NC_000012.12:g.40249830T>G
NG_011709.1:g.29820T>G
NG_011709.2:g.29835T>G
NM_198578.4:c.843T>GMANE SELECT
NP_940980.4:p.Asn281Lys
NC_000012.11:g.40643632T>G
NM_198578.3:c.843T>G

Protein change:

N281K

Molecular consequence:

NM_198578.4:c.843T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

cytochrome oxidase subunit 1, partial (mitochondrion) [Cionus hortulanus]
cytochrome oxidase subunit 1, partial (mitochondrion) [Cionus hortulanus]
gi|1169312888|gb|ARB59837.1|

Protein
ubiquitin C-terminal hydrolase [Gaeumannomyces tritici R3-111a-1]
ubiquitin C-terminal hydrolase [Gaeumannomyces tritici R3-111a-1]
gi|402082509|gb|EJT77527.1||gnl|WGS |GGTG_02634T0

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV005031517	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Nov 14, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV005031517

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Nov 14, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV005031517.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.N281K variant (also known as c.843T>G), located in coding exon 8 of the LRRK2 gene, results from a T to G substitution at nucleotide position 843. The asparagine at codon 281 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine